QUESTION ASKED: This study aimed to address the question of which modality for adjuvant breast radiotherapy costs more: whole breast radiotherapy (WBRT) or accelerated partial breast irradiation (APBI) with balloon-based brachytherapy. Using time-driven activity-based costing (TDABC), we were able to evaluate the fundamental cost based on resources consumed rather than charges billed to the payer.
METHODS:
For WBRT (25 fractions with 5-fraction boost) and APBI (10 fractions twice daily), process maps were created outlining each activity from consultation to posttreatment follow up ( Figure 1 ). Through staff interviews, time estimates were obtained for each activity. The capacity cost rate (CCR), defined as cost per minute, was calculated for personnel, equipment, and physical space. Total cost was calculated by multiplying the time required of each resource by its CCR. This was then summed and combined with the cost of consumable materials.
MAIN RESULTS:
The total cost for WBRT was $5,333 and comprised 56% personnel costs and 44% space/equipment costs. For APBI, the total cost was $6,941 (30% higher than WBRT) and comprised 51% personnel costs, 6% space/equipment costs, and 43% consumable materials costs. The attending physician had the highest CCR of all personnel ($4.28/min), and APBI required 24% more attending time than WBRT. The most expensive activity for APBI was balloon placement and for WBRT it was CT simulation.
BIAS, CONFOUNDING FACTOR(S), DRAWBACKS:
This study used data based on our local costs and institutional procedures. Generalizability outside of our department is therefore limited. In addition, our analysis accounted for departmental overhead, but did not measure hospital-wide overhead, such as information technology, marketing, lobby space, and hospital administration. Lastly, our time estimates came from interviews as opposed to direct measurements from patient encounters. This was done to prevent potential outliers from impacting our findings.
REAL-LIFE IMPLICATIONS:
The United States spends far more on health care than any other nation, and one of the key driving factors in this is a reimbursement system that rewards volume. As a departure from this, Michael Porter has advocated for a system based on value, defined as health outcomes achieved per dollar spent. To incentivize value, reimbursement must transition to bundled payments for the comprehensive management of a medical condition. In addition, transparent outcome reporting would hold physicians accountable for the quality of care. To formulate bundled payments, it is essential to have a thorough understanding of cost. TDABC is a bottom-up costing method with granular calculations based on personnel, space, equipment, and material resources consumed. This is in contrast to other costing methods which are primarily founded on charges billed to the payer. Ours is the first study to apply TDABC to breast radiotherapy, and has provided insight regarding what drives the higher cost for APBI compared with WBRT. More importantly, we hope it will lead to further research aimed at lowering health care costs and defining bundled payments. 
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Materials and Methods
For WBRT (25 fractions with five-fraction boost) and APBI (10 fractions twice daily), process maps were created outlining each activity from consultation to post-treatment follow up. Through staff interviews, time estimates were obtained for each activity. The capacity cost rates (CCR), defined as cost per minute, were calculated for personnel, equipment, and physical space. Total cost was calculated by multiplying the time required of each resource by its CCR. This was then summed and combined with cost of consumable materials.
Results
The total cost for WBRT was $5,333 and comprised 56% personnel costs and 44% space/equipment costs. For APBI, the total cost was $6,941 (30% higher than WBRT) and comprised 51% personnel costs, 6% space/equipment costs, and 43% consumable materials costs. The attending physician had the highest CCR of all personnel ($4.28/min), and APBI required 24% more attending time than WBRT. The most expensive activity for APBI was balloon placement and for WBRT was computed tomography simulation.
Conclusion
APBI cost more than WBRT when using the dose/fractionation schemes analyzed. Future research should use time-driven activity-based costing to better understand cost with the aim of reducing expenditure and defining bundled payments.
INTRODUCTION
The cost of health care in the United States far exceeds that of any other nation, 1 yet our expenditure has not led to superior health outcomes. One of the driving forces of this is our reimbursement system, which rewards physicians for volume rather than quality. The concept of value in health care, as described by Porter and colleagues, 2-5 is defined as the ratio of the quality of health outcomes achieved to dollars spent in the management of a specific medical condition. Thus, shifting toward a value-based health care system would benefit patients while decreasing the financial burden on society.
To incentivize value, Porter and colleagues [2] [3] [4] [5] proposed a model encompassing transparent reporting of outcomes and reimbursement as bundled payments. Physicians would be paid for managing a medical condition, rather than for each individual service, promoting cost efficiency. Furthermore, physicians' accountability for outcomes creates the incentive to deliver the highest-quality care. A transition to this system requires a detailed understanding of health care costs. Traditional costing methods that use ratios ofcost-to-charges(RCC)or relative value units (RVU) rely on invalid assumptions. Time-driven activity-based costing (TDABC) is a bottom-up accounting method described by Kaplan et al, 6 where the cost of a service is estimated on the basis of the amount of resource capacity that is used in the process. Few studies have used the more granular method of TDABC to assess cost of radiotherapy techniques. 7, 8 Afterbreast-conservingsurgeryforearlybreastcancer,adjuvant radiotherapy traditionally entails external-beam radiation to the whole breast. However, selected patients are candidates for accelerated partial-breast irradiation (APBI), 9 which offers the advantage of improved convenience. In this study, TDABC was used to estimate cost for the delivery of both whole-breast radiotherapy (WBRT) and APBI using balloon-based brachytherapy.
MATERIALS AND METHODS
Initial Evaluation
Women with early-stage invasive breast cancer are referred to our clinic in either the postoperative or preoperative setting. During initial consultation, candidates for APBI are counseled regarding their options, and the treatment technique is chosen mutually between the patient and physician. Patients who are initially seen preoperatively return for a postoperative visit to review their surgical pathology and to determine if the plan requires modification.
Balloon-Based APBI Patients undergo computed tomography (CT) to assess the surgical cavity for balloon placement. If the cavity is too large, the scan is repeated 1 week later. Once the cavity is acceptable, a Contura multi-lumen balloon catheter (Hologic, Bedford, MA) is inserted under local anesthesia in the high-dose rate-brachytherapy (HDR) suite, and the patient undergoes CT simulation. All patients receive 1 week of prophylactic antibiotics. A treatment plan is created to deliver 34 Gy in 10 fractions over 5 days to the surgical cavity plus 1-cm margin. Treatment is delivered using an HDR afterloader. Before each fraction, the patient is assessed by the physician for toxicity and to verify catheter positioning. Treatment is supervised by a physician, nurse, physicist, resident, and dosimetrist. The balloon is then explanted and the patient returns for follow up 2 to 4 weeks later.
Whole-Breast Radiotherapy
Patients undergo CT simulation in the supine position on a breast board; selected patients are treated in the prone position on the basis of anatomy. Patients with left-sided tumors whose hearts would lie within the radiotherapy fields are treated with active breathing control. An initial plan is designed, using opposed tangent photon fields to 50 Gy in 25 daily fractions using three-dimensional conformal technique. This is followed by a 10-Gy boost in five fractions to the surgical cavity, using either tangent photon fields, electron fields, or a photon/ electron mix. Setup verification is performed using an electronic portal imaging device upon initiation of a new plan, and subsequentlyonce every five fractions. Patients are evaluatedin clinic every five fractions, or any time there are concerns. Four to 6 weeks after treatment, patients return for follow up. Alternatively, selected patients are treated using hypofractionated WBRT to 42.56 Gy in 16 fractions followed by a four-fraction boost to 10.64 Gy. The remainder of the treatment process is identical to conventional WBRT.
Time-Driven Activity-Based Costing
The application of TDABC to health care has been described by Kaplan and Porter. 10 Our analysis includes the following steps:
1. Create process maps: Outlines were generated listing each process involved in the delivery of adjuvant radiotherapy. Process maps were then created for each process and displayed in Visio format. The process map entails a flowchart delineating each activity in the given process. For every activity, the involved personnel, facility space, and equipment were recorded, as well as the materials consumed. The frequency of occurrence was noted because some activities are not performed for every patient. Data were obtained from interviews with involved personnel and from observing clinic workflow. A process map outlining an initial consultation for breast brachytherapy is shown in Figure 1 . The corresponding process map for WBRT is included in Appendix Figure A1 (online only).
2. Obtain time estimates: Estimates were made regarding the duration of activities required for involved personnel, equipment, and space. Note was made of patient factors affecting the time to complete a task. Given the potential outliers among individual patient care cycles, time estimates were based on staff interviews rather than prospective patient data. Such interviews are integral in the methodology described by Kaplan et al, 6, 10 Check-in and registration less subject to outliers than patient tracking. A total of 27 staff members were interviewed. Estimates were validated by comparing them to data obtained from patient tracking. 3. Estimate the cost of patient care resources: The annual cost was estimated for personnel, equipment, and physical space. For personnel, annual cost comprised salary, benefits, supervision costs, and malpractice insurance. To maintain privacy, individual salaries were not used. Rather, data were taken from published median salaries specific to Richmond, VA. For attending physicians, Medical Group Management Association data were used, 11 and residents' published salaries were used. For all other employees, median salary data were taken from Salary.com. 11 Employees in a supervisory role were assigned the 75th percentile salary for their position. Supervision costs were estimated on the basis of the annual cost of the supervisor, the proportion of his or her time spent in a supervisory role, and the number of individuals he or she supervised. For equipment, annual cost comprised yearly depreciation and maintenance costs. For facility space, annual cost comprised construction depreciation, housekeeping, maintenance, utility costs, and square footage of the space used. Variability in construction costs between different rooms within the department was also accounted for. 4. Estimate the CCR: CCR is defined as the cost per unit time (dollars per minute), for personnel, equipment, and physical space. To calculate this, the annual capacity in minutes was estimated for each of the above resources. For personnel, this was based on number of clinical days worked per year and average number of clinical minutes worked per day. Vacation, holidays, leave, conferences, breaks, research, and administrative time were accounted for. The capacity for both equipment and space was determined on the basis of their available clinical days per year and average minutes per day. For each resource, annual cost was then divided by annual capacity to determine the CCR. 5. Calculate the total cost of patient care: For each activity from every process, the time estimate was multiplied by the CCR for all involved resources to calculate the cost. The sum of all activity costs plus the cost of any consumable materials was calculated to estimate the total cost for care delivery.
RESULTS
Breast Brachytherapy
Process maps include initial consultation, reevaluation, procedure planning, balloon placement, treatment planning, treatment delivery, balloon explant, follow up, and billing. The total cost of breast brachytherapy was $6,941 and comprised 51% personnel costs, 6% space and equipment costs, and 43% consumable materials costs. These materials included the balloon catheter, surgical supplies, local anesthesia, dressings,a 7-day supply of prophylactic cephalexin, and loose-fitting bras provided by the department. Table 1 shows the APBI cost breakdown by process. The most expensive process was balloon placement ($3,372), representing 48.6% of the total cost. The cost of delivering a single treatment was $246, representing 3.5% of the total treatment cost, and the 10 fractions in aggregate cost $2,459, representing 35% of the total cost.
Whole-Breast Radiotherapy
Process maps created for WBRT include initial consultation, reevaluation, CT simulation, treatment planning, boost planning, new start, treatment delivery, on-treatment visit, close out, follow up, and billing. The total cost was $5,333 and comprised 56% personnel costs and 44% space and equipment costs. No significant materials were consumed. Table 2 shows the WBRT cost breakdown by process. The most expensive process was CT simulation ($358), representing 6.7% of the total cost. The cost of delivering a single treatment was $104, representing 2.0% of the total treatment cost. The process is repeated 28 times during a treatment course (30 fractions, excluding new start for initial and boost fields), and in aggregate, treatment delivery cost $2,914, representing 54.7% of total cost.
Hypofractionation
The total cost for hypofractionated radiotherapy (16 fractions with a four-fraction boost) was $4,074, corresponding to a cost reduction of 24% compared with conventional fractionation. This cost comprised 60% personnel costs and 40% space and materials cost. 81% lower for APBI compared with conventional WBRT. The attending physician had the highest CCR of all personnel, and APBI required 24% more attending time than conventional WBRT.
DISCUSSION
Our study found APBI using balloon-based brachytherapy to be 30% more expensive than WBRT. Porter et al [2] [3] [4] [5] define value as health outcomes achieved per dollar spent, and cost is therefore only the denominator in the value equation. Without outcomes, conclusions regarding the comparative value between modalities cannot be reached. Breast brachytherapy offers low toxicity rates and shortened treatment, 12 thereby decreasing the patient's financial burden from travel and missed work. Thus, it may still demonstrate value despite the increased cost. A phase III trial comparing the efficacy and toxicity of the two modalities has completed accrual, and is currently awaiting data maturation. 13 Personnel expense, particularly attending physician expense, was the major driver of cost for both radiotherapy techniques. This presents an opportunity to improve cost efficiency through resource reallocation. Christensen Grossman and Hwang 14 proposed that productivity is optimized when health care workers function at the highest level their license permits. In this vein, further analysis of our data can identify tasks where involvement of the attending physician is not essential. Costs can be reduced by reassigning these tasks to staff members with lower CCRs. For example, the attending physician may not need to oversee an entire HDR treatment delivery, which is already supervised by a nurse, resident, and physicist trained in radiation safety. Similarly, when bleeding occurs after balloon placement, the nurse or resident would be qualified to hold pressure instead of the attending physician. Cost efficiency could thereby be improved by minimizing use of the attending physician's time.
Understanding the true cost to manage a condition is critical to improving efficiency and enhancing value. To our knowledge, this is the first study applying TDABC to breast radiotherapy. TDABC is a powerful method that estimates the cost of care on the basis of the time required of every involved resource. Traditional costing methods include RCC-and RVU-based metrics. These methods falsely assume that across all services in a department, there is a fixed relationship between cost and charges or between cost and RVU, respectively. Both RCC and RVU are top-down methods and fail to capture the fundamental source of cost, which includes personnel, space, equipment, and materials.
By quantifying bottom-up cost, TDABC adds a novel perspective to comparative effectiveness and health services research. Using this tool, the anesthesiology department at the University of Texas MD Anderson Cancer Center measured savings associated with implementing a standardized workflow for preoperative assessments. By analyzing their process map, further cost-reducing measures were identified, resulting in total savings of 46%. 15 Similarly, researchers at the Harvard Business School conducted a study applying TDABC to medical services at several organizations. They learned that adding certain upfront steps could actually reduce overall total cost. For example, performing a nerve block before rotator cuff repair lowers the cumulative expense by decreasing costly time spent in the postanesthesia care unit. 16 In this regard, TDABC can provide insight that other costing methods overlook.
Value-based health care is of increasing interest to the field of radiation oncology. In a pilot study, the University of Texas MD Anderson Cancer Center applied TDABC to two patients undergoing head and neck radiotherapy using either photon or proton therapy. Although proton therapy used costlier technology, the toxicity experienced during photon therapy necessitated intravenous hydration, nutrition consultation, pain management, feeding tube placement, and replanning because of weight loss. When considering costs for the entire treatment course, expenditure was only 6% higher for proton therapy, which is commonly believed to cost dramatically more. 8 In The discrepancy between Medicare reimbursements and our cost estimates can be explained by several factors. Our analysis accounted for departmental overhead costs (housekeeping, utilities, and billing), but did not measure hospitalwide overhead, such as information technology, marketing, lobby space, and hospital administration. Additionally, a margin between departmental costs and charges is necessary to offset the cost of activities that are not directly reimbursed. This includes research, resident and student education, and care for indigent patients.
The 2013 Choosing Wisely guidelines recommend consideration of short-course radiotherapy for all women older than 50 years after breast-conserving surgery. 20 Based on our Although the impact of Choosing Wisely remains to be seen, financial incentives such as payment reform have the potential to significantly change practice patterns. The APBI analysis assumed the use of the Contura multilumen balloon catheter; alternative devices include the MammoSite single-lumen catheter (Hologic, Bedford, MA) and the SAVI strut-based applicator (Cianna Medical, Aliso Viejo, CA).The cost of the MammoSitecatheter is equivalent to that of the Contura, whereas using the SAVI would result in a 6.5% increase in materials costs and a 2.8% increase in total cost.
In our academic department, physician duties are divided between residents and attending physicians. For the delivery of APBI, overall physician time includes 39% attending time and 61% resident time. For WBRT, this includes 42% attending time and 58% resident time. Because our findings are specific to our institution, it would not make sense to apply them to a nonteaching setting. However, our conclusion that APBI costs more than WBRT would probably hold true, given the similar distribution of attending versus resident time between the two modalities.
Although economic comparisons often include a sensitivity analysis, this study is purely descriptive and makes no statistical inference. Our data are based on averages and single values, for which variability assessments are either unavailable or not meaningful. Because of these considerations, we do not believe that it would be methodologically correct to perform a sensitivity analysis.
One limitation to our study is that time estimates primarily came from interviews as opposed to measurements from patient encounters. This was done because individual patient care cycles are subject to variability, and prospective recording of data from a large sample of patients would not be feasible with the resources available. Future investigations should involve larger study teams with the capability to collect data from large numbers of treatment courses. Porter, Kaplan, and colleagues 2-5 advocate reporting cost and outcomes over the entire care cycle for a medical condition. Adjuvant radiotherapy comprises only part of the management of early-stage breast cancer, which also includes diagnosis, staging, surgery, systemic therapy, and surveillance. Thus, although this study investigates a critical step in breast cancer treatment, a more inclusive study would be necessary to create a comprehensive condition-specific bundle. Lastly, our analysis is based on local costs and institutional procedures. Generalizability to other departments may therefore be limited, particularly those in which the brachytherapy balloon is placed by a surgeon and those in the private practice setting.
In conclusion, this study found breast brachytherapy to be more expensive than WBRT in our department. Furthermore, our analysis demonstrates that the TDABC can be applied to breast radiotherapy. The rising expense of health care will ultimatelynecessitate movement away fromthe fee-for-service reimbursement model, and understanding cost will be essential. Engagement of both physicians and administrators in cost-related research will therefore be of critical importance.
